Prevention of Human Immunodeficiency Virus Infection Among Intravenous Drug Users in New South Wales,Australia: The Needles and Syringes Distribution Programme Through Retail Pharmacies

Abstract

Prevalence of Human Immunodeficiency Virus (HIV) infection among 12, 000 intravenous (i.v.) drug users in New South Wales (NSW) was estimated to be very low in 1985. However, a large increase of HIV infection in this population group could result within a short period.

The NSW government amended existing legislation to permit the sale and possession of sterile needles and syringes. A programme to promote the sale of needles and syringes was launched jointly with the Pharmacy Guild of Australia (NSW Branch) in December 1986. Favourable changes in pharmacists' attitudes were noted four months later. The distribution scheme became an important component of the NSW prevention programme.

There are 2, 039 retail pharmacies throughout NSW. The number of sterile needles and syringes sold through these outlets increased from 4, 200 in January 1987 to 51, 000 in November 1987 with a total of 422, 000 dispensed over this period. The percentage of Pharmacy Guild members involved in the programme increased from 0.5% to 22.5%, covering 38% of the state by November 1987.

During 1987, HIV infection among i.v. drug users remained low. This suggests that the needles and syringes distribution programme contributed significantly towards limiting the spread of HIV infection among i.v. drug users.

Keywords

Human Immunodeficiency Virus infection and intravenous drug users Needle distribution

Get full access to this article

View all access options for this article.

References

1. Scottish Home and Health Department: HIV Infection in Scotland. Report of the Scottish Committee on HIV Infection and Intravenous Drug Misuse, 1986.

2. Drucker E : AIDS and addiction in New York City. Am J Drug Alc Abuse 1986;12:165.

3. Robertson JR , Bucknall ABV , Welsby PD et al: Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br Med J 1986;292:527.

4. Ferroni P , Geroldi D , Galli C et al: HTLV-III antibody among Italian addict. Lancet 1985;ii:52.

5. Hirschel B , Carpentier N , Male PJ et al: Lymphadenopathy virus (LAV/HTLV-III) infection in Geneva heroin addicts: high prevalence of lymphadenopathy, low incidence of AIDS. Proceedings of the 2nd International Conference on AIDS, Paris, France, 1986.

6. WHO Collaborating Centre on AIDS. AIDS and Drug Addicts in Europe, Letter to Lancet 1987, September 12th, 626.

7. Australian Bureau of Statistics: Preliminary Report of the 1986 Census, 1987.

8. Sandland R: Methods of estimating the number of heroin users in New South Wales. In-house report of the NSW Drug and Alcohol Authority, A84/3, 1984.

9. Sandland R: Estimation of the number of heroin users in NSW using police arrest data: development of a statistical model. Research Grant Report of NSW Drug and Alcohol Authority, B86/1, 1986.

10.

10. Reilly C, Homel P: 1986 Survey of recreational drug use and attitudes of 15-to 18-year-olds in Sydney. In-house report of the NSW Drug and Alcohol Authority, A87/4, 1987.

11.

11. Chaisson RE , Moss AR , Onishi R et al: Human Immunodeficiency Virus infection in heterosexual intravenous drug users in San Francisco. Am J Pub Hlth 1987;7711:1169.

12.

12. Blacker P , Tindall B , Wodak A , Cooper DA : Exposure of intravenous drug users to AIDS retrovirus, Sydney, 1985. Aust NZ J Med 1986;16:686.

13.

13. Goh T, Nuyen K, Lee T: Prevalence of HIV infection among heroin addicts in methadone programmes, December 1986. Report of NSW Department of Health, 1987.